Filippo Pietrantonio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Filippo pietrantonio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Filippo Pietrantonio Today - Breaking & Trending Today

Sotorasib Plus Panitumumab Dubbed New Standard Care for Metastatic Colorectal Cancer

Sotorasib Plus Panitumumab Dubbed New Standard Care for Metastatic Colorectal Cancer
cancertherapyadvisor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cancertherapyadvisor.com Daily Mail and Mail on Sunday newspapers.

Filippo Pietrantonio , Amgen Inc , Istituto Nazionale ,

Sotorasib Plus Panitumumab Dubbed New Standard Care for Metastatic Colorectal Cancer

The combination of sotorasib and panitumumab outperformed investigator’s choice of therapy in patients with KRAS G12C-mutated metastatic colorectal cancer. ....

Filippo Pietrantonio , Amgen Inc , Istituto Nazionale ,

Looking at Novel Treatments in Lung and Genitourinary Cancers From ESMO 2023: Drs Janne and Bastos

OncLive® will be LIVE with OncLive® News Network: On Location at the 2023 ESMO Congress. Each day, we will broadcast a series of interviews with top thought leaders, to learn their thoughts and reactions to data presented across oncology during the conference. ....

Caroline Seymour , Filippo Pietrantonio , Jacob Sands , Bruno Bastos , News Network , Congress At Onclive , Welcome To Onclive News Network , Onclive News Network , Onclive News , Im Caroline ,

Combination Therapy More Than Doubles Survival in Patients With Metastatic Colorectal Cancer Compared to Standard of Care

This is the first phase 3 trial to evaluate a KRAS G12C-inhibitor plus an anti-epidermal growth factor receptor antibody for this type of colorectal cancer.
....

Jo Panuwat , Filippo Pietrantonio , Istituto Nazionale , Davidm Reese , European Society For Medical Oncology , New England Journal , European Society , Medical Oncology , Taiho Oncology ,

Lumakras Plus Vectibix Improves PFS in Colorectal Cancer

The combination of Lumakras and Vectibix led to better progression-free survival compared with standard of care in patients with chemorefractory metastatic colorectal cancer harboring KRAS G12C mutations. ....

Filippo Pietrantonio , Lumakras Vectibix , New England Journal , Colorectal Cancer , Esmo 2023 ,